SAN JOSE, CA / ACCESS Newswire / April 1, 2026 / VSee Health, Inc. (NASDAQ:VSEE), a leader in AI-powered telehealth technology and high-acuity virtual care solutions, today reported its financial and operational results for the full year ended December 31, 2025. The Company delivered strong top-line growth and meaningful margin improvement while significantly narrowing its net loss.

Key Financial Highlights (Year-over-Year Comparisons)

Revenue increased 40% to $14,618,184 in 2025 from $10,421,352 in 2024

Gross margin rose 2% to $7,355,965 from $7,177,580

Operating expenses declined sharply by 76%

The Company strengthened its balance sheet through multiple debt to equity conversions

Cash and liquidity: Cash and cash equivalents increased to $5,266,286 at December 31, 2025, from $326,115 at December 31, 2024

Key Business Highlights

During 2025 VSee Health focused on reducing public expenses associated with the IPO, and growth in its telehealth clinical services group.

The company derived its 40% revenue growth by targeting large IDN's (Integrated Health Networks) in the USA. The team signed several large scale multi-year contracts (one for $10 million per year previously announced) in early and mid 2025. The telehealth revenue for new large healthcare institutional accounts takes several months to begin, as the operations are complex and must be integrated into VSee heath's technology before rolling out services. This is particularly important for our investors to understand that a majority of 2025 growth was in the second half of the year, and subsequently provides solid future growth in those accounts during 2026 as services continue to roll out to as many as 20 states this fiscal year. Management is bullish for 2026 growth as these contracts are continuing to build revenue and adding additional telehealth services.

VSee Health continues to service government accounts such as NASA. In 2025 VSee Labs Inc was nominated and approved for Fedramp High status with the Federal Government as a technology partner. This was achieved through its HHS (Health and Human Services) contract awarded during 2024 and into 2025. VSee continues to pursue several government healthcare related projects in 2026.

VSee Health experienced extremely high legal, accounting, and integration expenses associated with the IPO process in 2024 and 2025. The executive team worked diligently with the Board of Directors to streamline all operations during 2025. VSee believes it can continue to lower its operating costs while growing revenue during 2026.

Outlook and Strategic Position

VSee Health enters 2026 with a fully integrated digital-to-physical care platform, scalable AI telehealth infrastructure, and proven high-acuity clinical delivery. The Company continues to target the rapidly growing hybrid care market while focusing on operational efficiencies, contract renewals, and new enterprise wins. Management remains committed to achieving sustainable profitability and delivering long-term shareholder value.

Investors and interested parties are encouraged to review the complete 10-K filing, which includes detailed financial statements, Management's Discussion and Analysis, risk factors, and business overview, at www.sec.gov or VSeeHealth.com/investors.

About VSee Health, Inc. (NASDAQ:VSEE)

VSee Health is a leader in AI-powered telehealth technology, providing configurable virtual care solutions-including secure video, remote monitoring, AI-enhanced workflows, and seamless EHR integrations-for health systems, government agencies, and large enterprises. Through its iDoc subsidiary, the Company also delivers high-acuity specialty physician services in neurology, tele-radiology, cardiac, and critical care via telehealth.

Forward-Looking Statements

Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

Contact:

VSee Health
Anne Chang
media@vsee.com

VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com

SOURCE: VSee Health, Inc.

View the original press release on ACCESS Newswire

VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet